Forbes - Pharma & Healthcare
3.4 billion individuals live with a neurological condition, making disorders affecting the nervous system the leading cause of illness and disability globally.
Prioritizing mental health in the workplace has become not just a necessity but a moral imperative, and top of mind for many leaders.
Veneer techs have gained popularity on social media, but dentists warn these people are performing dental work illegally—and patients are risking their lives for a cheap fix.
As Medicaid unwinding continues hundreds of thousands and maybe millions more will become uninsured. This renews the longstanding discussion of the problem of uninsured.
The success story at Umeå University underscores the potent combination of perseverance, innovation, and the promise of gene therapy in confronting ALS.
Skepticism may be warranted when Medicare says it expects to spend $3.5 billion on the Alzheimer’s disease drug Leqembi.
Build your own newsfeed
Ready to give it a go?
Start a 14-day trial, no credit card required.